Skip to main content
. 2022 Aug 30;25:101525. doi: 10.1016/j.tranon.2022.101525

Fig. 6.

Fig 6

The cancer-promoting role of E2F7 in ccRCC (A) Validation of the knockdown effect of E2F7 via western blotting. (B) Effect of E2F7 knockdown on apoptosis in OSRC-2 and 786-O cells. (C) Proliferation of OSRC-2 and 786-O cells detected by CCK8 assay. (D) Scratch assay in OSRC-2 and 786-O cells. (E) Migration and invasion ability of OSRC-2 and 786-O cells measured via transwell assay. (F) Cell cycle estimated by flow cytometry in OSRC-2 and 786-O cells.